139.32
-4.22
(-2.94%)
At close: April 17 at 4:00:03 PM EDT
138.80
-0.52
(-0.37%)
After hours: April 17 at 7:46:24 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 16 | 15 | 18 | 18 |
| Avg. Estimate | 3.11 | 3.31 | 13.67 | 15.23 |
| Low Estimate | 2.8 | 3.14 | 13 | 14.02 |
| High Estimate | 3.3 | 3.44 | 14.31 | 16.04 |
| Year Ago EPS | 3.47 | 3.75 | 14 | 13.67 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 14 | 14 | 16 | 16 |
| Avg. Estimate | 2.01B | 2.05B | 8.25B | 8.65B |
| Low Estimate | 1.92B | 2B | 8.06B | 8.29B |
| High Estimate | 2.07B | 2.11B | 8.51B | 9.04B |
| Year Ago Sales | 2.09B | 2.12B | 8.28B | 8.25B |
| Sales Growth (year/est) | -3.81% | -3.33% | -0.35% | 4.83% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 3.41 | 3.67 | 3.85 | 3.43 |
| EPS Actual | 3.47 | 3.75 | 3.35 | 3.43 |
| Difference | 0.06 | 0.08 | -0.5 | 0 |
| Surprise % | 1.66% | 2.12% | -13.05% | 0.14% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 3.11 | 3.31 | 13.67 | 15.23 |
| 7 Days Ago | 3.15 | 3.35 | 13.78 | 15.37 |
| 30 Days Ago | 3.21 | 3.37 | 13.92 | 15.63 |
| 60 Days Ago | 3.43 | 3.52 | 14.2 | 15.99 |
| 90 Days Ago | 3.5 | 3.59 | 14.47 | 16.49 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | 1 | 2 | 1 | 1 |
| Down Last 7 Days | 5 | 2 | 5 | 6 |
| Down Last 30 Days | 6 | 4 | 6 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ICLR | -10.48% | -11.67% | -2.33% | 11.40% |
| S&P 500 | 7.04% | 5.20% | 8.89% | 14.14% |
Upgrades & Downgrades
| Downgrade | TD Cowen: Buy to Hold | 4/14/2025 |
| Maintains | Truist Securities: Buy to Buy | 4/10/2025 |
| Downgrade | Barclays: Overweight to Equal-Weight | 4/10/2025 |
| Maintains | Mizuho: Outperform to Outperform | 4/9/2025 |
| Maintains | Citigroup: Buy to Buy | 4/7/2025 |
| Downgrade | Goldman Sachs: Buy to Neutral | 3/21/2025 |
Related Tickers
IQV IQVIA Holdings Inc.
143.91
-3.05%
MEDP Medpace Holdings, Inc.
296.28
-0.07%
WAT Waters Corporation
321.01
-0.03%
LH Labcorp Holdings Inc.
217.12
-1.56%
MTD Mettler-Toledo International Inc.
1,004.96
-1.15%
TMO Thermo Fisher Scientific Inc.
427.50
-2.13%
IDXX IDEXX Laboratories, Inc.
411.49
+2.26%
CRL Charles River Laboratories International, Inc.
106.05
+1.73%
DHR Danaher Corporation
186.83
-2.01%
DGX Quest Diagnostics Incorporated
163.80
-0.41%